Navigating Regulatory Change in Today’s Biotech Landscape Including your career.

events_1.jpg
When:  Feb 24, 2026 from 17:00 to 19:30 (PT)
The biotech and pharma regulatory landscape is evolving rapidly, shaped by shifting FDA expectations, market pressures, and a more complex development environment. These changes are not only influencing how drugs are developed and approved—but also how careers in regulatory affairs and drug development are built and sustained. Join us for an evening of conversation and connection at Day One Biopharma, where industry leaders will share perspectives on how the current regulatory climate is impacting biotech and pharma today—and what it means for professionals navigating their careers in this space. The evening will kick off with informal networking, followed by a panel discussion focused on the regulatory landscape and key takeaways from JPM, including how recent trends are influencing development strategy, regulatory decision making, and cross functional collaboration. Panelists will share practical insights from their roles across regulatory and development functions, with time built in for audience questions. The second half of the program will shift to a more interactive career focused panel, offering candid discussion around career paths in regulatory affairs and drug development, navigating change, and positioning yourself for growth in a dynamic industry. This session is designed to be highly conversational, with ample opportunity for audience Q&A. Whether you are early in your career, exploring your next step, or simply looking to stay close to how regulatory dynamics are evolving, this event offers a chance to learn, connect, and engage with peers across the biotech ecosystem. What to expect: Insights on today’s regulatory and development landscape and what’s changing Reflections and takeaways from JPM Career perspectives and advice from industry leaders Plenty of time for networking with peers and speakers We look forward to welcoming you for an engaging evening of discussion, learning, and community.